Covered recipient · General Payments record
EDWARD ALAN MALTBIE
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,692.93
- Reported across 181 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $454.00 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $175.25 | 20 |
| Ardelyx, Inc. | $100.67 | 5 |
| GENZYME CORPORATION | $56.36 | 3 |
| Celgene Corporation | $42.67 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.51 | 2 |
| Janssen Biotech, Inc. | $19.29 | 1 |
| Braintree Laboratories, Inc. | $15.44 | 1 |
| Ferring Pharmaceuticals Inc. | $14.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.48 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949332 | CMS |
| ABBVIE INC. | $0.80 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949336 | CMS |
| ABBVIE INC. | $16.91 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949340 | CMS |
| ABBVIE INC. | $12.33 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949345 | CMS |
| ABBVIE INC. | $16.15 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949349 | CMS |
| ABBVIE INC. | $2.45 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949353 | CMS |
| ABBVIE INC. | $11.13 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949357 | CMS |
| ABBVIE INC. | $8.47 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949361 | CMS |
| ABBVIE INC. | $12.66 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949365 | CMS |
| ABBVIE INC. | $1.13 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949369 | CMS |
| ABBVIE INC. | $9.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949373 | CMS |
| ABBVIE INC. | $4.45 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949377 | CMS |
| ABBVIE INC. | $6.52 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949381 | CMS |
| ABBVIE INC. | $12.70 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949385 | CMS |
| ABBVIE INC. | $1.78 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949389 | CMS |
| ABBVIE INC. | $15.53 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949393 | CMS |
| ABBVIE INC. | $17.19 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949396 | CMS |
| ABBVIE INC. | $4.16 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949400 | CMS |
| ABBVIE INC. | $6.59 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949404 | CMS |
| ABBVIE INC. | $0.69 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104949409 | CMS |
| Ardelyx, Inc. | $25.89 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146693872 | CMS |
| Ardelyx, Inc. | $19.92 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146693874 | CMS |
| Ardelyx, Inc. | $20.43 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146693876 | CMS |
| Ardelyx, Inc. | $14.45 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146693878 | CMS |
| Ardelyx, Inc. | $19.98 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146693880 | CMS |
| Braintree Laboratories, Inc. | $15.44 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125516105 | CMS |
| Celgene Corporation | $14.91 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101152395 | CMS |
| Celgene Corporation | $27.76 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101152403 | CMS |
| Ferring Pharmaceuticals Inc. | $14.81 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137493089 | CMS |
| GENZYME CORPORATION | $17.02 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139719964 | CMS |
| GENZYME CORPORATION | $19.34 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139719970 | CMS |
| GENZYME CORPORATION | $20.00 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139719974 | CMS |
| Janssen Biotech, Inc. | $19.29 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078667243 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.32 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137628477 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.19 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137628479 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.